GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial

NCT02319577 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy